173 related articles for article (PubMed ID: 37740222)
21. Regulation of BAX and BCL-2 expression in breast cancer cells by chemotherapy.
Gibson LF; Fortney J; Magro G; Ericson SG; Lynch JP; Landreth KS
Breast Cancer Res Treat; 1999 May; 55(2):107-17. PubMed ID: 10481938
[TBL] [Abstract][Full Text] [Related]
22. p38 MAPK/MK2-mediated induction of miR-34c following DNA damage prevents Myc-dependent DNA replication.
Cannell IG; Kong YW; Johnston SJ; Chen ML; Collins HM; Dobbyn HC; Elia A; Kress TR; Dickens M; Clemens MJ; Heery DM; Gaestel M; Eilers M; Willis AE; Bushell M
Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5375-80. PubMed ID: 20212154
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of novel orthotopic nude mouse models for human small-cell lung cancer.
Isobe T; Onn A; Morgensztern D; Jacoby JJ; Wu W; Shintani T; Itasaka S; Shibuya K; Koo PJ; O'Reilly MS; Herbst RS
J Thorac Oncol; 2013 Feb; 8(2):140-6. PubMed ID: 23328546
[TBL] [Abstract][Full Text] [Related]
24. The p38/MK2 Pathway Functions as Chk1-Backup Downstream of ATM/ATR in G
Luo D; Mladenov E; Soni A; Stuschke M; Iliakis G
Cells; 2023 May; 12(10):. PubMed ID: 37408221
[TBL] [Abstract][Full Text] [Related]
25. The novel role of etoposide in inhibiting the migration and proliferation of small cell lung cancer and breast cancer via targeting Daam1.
Yu X; Xu T; Su B; Zhou J; Xu B; Zhang Y; Zhu Y; Jiang N; He Z
Biochem Pharmacol; 2023 Apr; 210():115468. PubMed ID: 36858182
[TBL] [Abstract][Full Text] [Related]
26. Her2 promotes early dissemination of breast cancer by suppressing the p38-MK2-Hsp27 pathway that is targetable by Wip1 inhibition.
Wang J; Wang G; Cheng D; Huang S; Chang A; Tan X; Wang Q; Zhao S; Wu D; Liu AT; Yang S; Xiang R; Sun P
Oncogene; 2020 Oct; 39(40):6313-6326. PubMed ID: 32848211
[TBL] [Abstract][Full Text] [Related]
27. Mitogen-activated protein kinase-activated protein kinase 2 in neuroinflammation, heat shock protein 27 phosphorylation, and cell cycle: role and targeting.
Gurgis FM; Ziaziaris W; Munoz L
Mol Pharmacol; 2014 Feb; 85(2):345-56. PubMed ID: 24296859
[TBL] [Abstract][Full Text] [Related]
28. Mutation frequency and spectrum in lymphocytes of small cell lung cancer patients receiving etoposide chemotherapy.
Karnaoukhova L; Moffat J; Martins H; Glickman B
Cancer Res; 1997 Oct; 57(19):4393-407. PubMed ID: 9331103
[TBL] [Abstract][Full Text] [Related]
29. Mitogen-activated protein kinase-activated protein kinase-2 (MK2) and its role in cell survival, inflammatory signaling, and migration in promoting cancer.
Morgan D; Berggren KL; Spiess CD; Smith HM; Tejwani A; Weir SJ; Lominska CE; Thomas SM; Gan GN
Mol Carcinog; 2022 Feb; 61(2):173-199. PubMed ID: 34559922
[TBL] [Abstract][Full Text] [Related]
30. The MAPK-activated protein kinase 2 mediates gemcitabine sensitivity in pancreatic cancer cells.
Köpper F; Binkowski AM; Bierwirth C; Dobbelstein M
Cell Cycle; 2014; 13(6):884-9. PubMed ID: 24556918
[TBL] [Abstract][Full Text] [Related]
31. Generation and characterization of a stable MK2-EGFP cell line and subsequent development of a high-content imaging assay on the Cellomics ArrayScan platform to screen for p38 mitogen-activated protein kinase inhibitors.
Williams RG; Kandasamy R; Nickischer D; Trask OJ; Laethem C; Johnston PA; Johnston PA
Methods Enzymol; 2006; 414():364-89. PubMed ID: 17110203
[TBL] [Abstract][Full Text] [Related]
32. Intensified Beclin-1 Mediated by Low Expression of Mir-30a-5p Promotes Chemoresistance in Human Small Cell Lung Cancer.
Yang X; Bai F; Xu Y; Chen Y; Chen L
Cell Physiol Biochem; 2017; 43(3):1126-1139. PubMed ID: 28977798
[TBL] [Abstract][Full Text] [Related]
33. A small molecule Smac-mimic compound induces apoptosis and sensitizes TRAIL- and etoposide-induced apoptosis in breast cancer cells.
Bockbrader KM; Tan M; Sun Y
Oncogene; 2005 Nov; 24(49):7381-8. PubMed ID: 16044155
[TBL] [Abstract][Full Text] [Related]
34. Differential roles of checkpoint kinase 1, checkpoint kinase 2, and mitogen-activated protein kinase-activated protein kinase 2 in mediating DNA damage-induced cell cycle arrest: implications for cancer therapy.
Xiao Z; Xue J; Sowin TJ; Zhang H
Mol Cancer Ther; 2006 Aug; 5(8):1935-43. PubMed ID: 16928813
[TBL] [Abstract][Full Text] [Related]
35. The p38 MAPK-MK2 axis regulates E2F1 and FOXM1 expression after epirubicin treatment.
de Olano N; Koo CY; Monteiro LJ; Pinto PH; Gomes AR; Aligue R; Lam EW
Mol Cancer Res; 2012 Sep; 10(9):1189-202. PubMed ID: 22802261
[TBL] [Abstract][Full Text] [Related]
36. Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571.
Wang WL; Healy ME; Sattler M; Verma S; Lin J; Maulik G; Stiles CD; Griffin JD; Johnson BE; Salgia R
Oncogene; 2000 Jul; 19(31):3521-8. PubMed ID: 10918610
[TBL] [Abstract][Full Text] [Related]
37. p38MAPK inhibition: a new combined approach to reduce neuroblastoma resistance under etoposide treatment.
Marengo B; De Ciucis CG; Ricciarelli R; Furfaro AL; Colla R; Canepa E; Traverso N; Marinari UM; Pronzato MA; Domenicotti C
Cell Death Dis; 2013 Apr; 4(4):e589. PubMed ID: 23579276
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of MAPKAPK2/MK2 facilitates DNA replication upon cancer cell treatment with gemcitabine but not cisplatin.
Li Y; Köpper F; Dobbelstein M
Cancer Lett; 2018 Aug; 428():45-54. PubMed ID: 29704518
[TBL] [Abstract][Full Text] [Related]
39. Panobinostat synergistically enhances the cytotoxic effects of cisplatin, doxorubicin or etoposide on high-risk neuroblastoma cells.
Wang G; Edwards H; Caldwell JT; Buck SA; Qing WY; Taub JW; Ge Y; Wang Z
PLoS One; 2013; 8(9):e76662. PubMed ID: 24098799
[TBL] [Abstract][Full Text] [Related]
40. Cell cycle checkpoint evasion and protracted cell cycle arrest in X-irradiated small-cell lung carcinoma cells.
Smith PJ; Wiltshire M; Chin SF; Rabbitts P; Souès S
Int J Radiat Biol; 1999 Sep; 75(9):1137-47. PubMed ID: 10528922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
